Key result
In a series of 3 cases, thyrotoxic periodic paralysis was successfully managed with potassium correction, antithyroid drugs, and propranolol, with 0 patients experiencing recurrence.
Why the study?
Thyrotoxic periodic paralysis often goes unrecognized despite its life-threatening potential due to severe dysrhythmia from hypokalemia, and it can occur irrespective of age, sex, and race.
Case Report (n=3)
Thyrotoxic periodic paralysis can present with life-threatening ventricular arrhythmias in non-Asian populations, requiring prompt recognition, potassium correction, and treatment with antithyroid drugs and propranolol.
No takes yet. Share an insight, caveat, or question.
May inform acute thyrotoxic periodic paralysis management; leaves open prospective validation in larger cohorts.
Bilhă et al. (2020) conducted a case report in Thyrotoxic periodic paralysis (TPP) (n=3). Potassium correction, antithyroid agents, and propranolol was evaluated. In a series of 3 cases, thyrotoxic periodic paralysis was successfully managed with potassium correction, antithyroid drugs, and propranolol, with 0 patients experiencing recurrence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: